| Impaired parvocellular pathway in dyslexic children AF Farrag, EM Khedr, W Abel‐Naser European Journal of Neurology 9 (4), 359-363, 2002 | 63 | 2002 |
| Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study ESM Ali A, Sayed H, Farrag A Leukemia research 34 (11), 1447-52, 2010 | 11 | 2010 |
| Multimodal treatment of nasopharyngeal carcinoma in children, adolescents and young adults-extended follow-up of the NPC-2003-GPOH Study cohort and patients of the interim cohort T Römer, S Franzen, H Kravets, A Farrag, A Makowska, H Christiansen, ... Cancers 14 (5), 1261, 2022 | 9 | 2022 |
| Late Effects in Children, Adolescents and Young Adults with Nasopharyngeal Carcinoma Treated on the Multimodal GPOH-TRIALS NPC-1991, NPC-2003 and the NPC-Interim Registry U Kontny, H Kravets, S Franzen, M Buehrlen, A Farrag, T Feuchtinger, ... PEDIATRIC BLOOD & CANCER 66, S48-S49, 2019 | | 2019 |
| Prognostic Value of Plasma Epstein-Barr Viral Deoxyribonucleic Acid in Children and Adolescents with Nasopharyngeal Carcinoma in a Non-Endemic Region A Farrag, W Puppe, C Schmitt, S Franzen, U Kontny PEDIATRIC BLOOD & CANCER 65, S387-S388, 2018 | | 2018 |
| Thyroid Gland Dysfunction after Allogeneic Hematopoietic Stem Cell Transplantation in Children and Adolescents A Farrag, H Sayed, S Abdel-Hady, P Noelke, C Niemeyer, B Strahm PEDIATRIC BLOOD & CANCER 63, S164-S165, 2016 | | 2016 |
| EVALUATION OF AN ESTABLISHED TREATMENT RELATED MORTALITY RISK SCORE FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN IN A SINGLE CENTER OVER A TWENTY … A Farrag, T Vraetz, AMJ Peters, A Yoshimi, P Noellke, CM Niemeyer, ... PEDIATRIC BLOOD & CANCER 61, S202-S202, 2014 | | 2014 |
